STOCK TITAN

PTC Therapeutics to Present at the Evercore ISI 3rd Annual HealthCONx Conference

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Rhea-AI Summary

PTC Therapeutics (NASDAQ: PTCT) will present at the Evercore ISI 3rd Annual HealthCONx Conference on December 1, 2020, at 11:45 a.m. ET. This presentation, featuring a company overview, will be available via live webcast on PTC's website, with an archived version accessible for 30 days. PTC Therapeutics is a global biopharmaceutical company specializing in innovative treatments for rare disorders, emphasizing its commitment to meeting unmet medical needs through a diversified pipeline of transformative medicines.

Loading...
Loading translation...
Argus Session date unavailable
+1.78% session move Open Argus
Details

News Market Reaction – PTCT

The recorded move for PTCT in the trading session of this news was +1.78%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

SOUTH PLAINFIELD, N.J., Nov. 19, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company overview at Evercore ISI 3rd Annual HealthCONx Conference on Tuesday, December 1st at 11:45 a.m. ET.

The presentation will be webcast live on the Events and Presentations page under the investor relations section of PTC Therapeutics' website at www.ptcbio.com and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.

About PTC Therapeutics, Inc.

PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need.

FOR MORE INFORMATION PLEASE CONTACT:


Media: 

Investors:

Jane Baj 

Lisa Hayes

+1 (908) 912-9167

+1 (732) 354-8687

jbaj@ptcbio.com

lhayes@ptcbio.com 

Cision View original content:http://www.prnewswire.com/news-releases/ptc-therapeutics-to-present-at-the-evercore-isi-3rd-annual-healthconx-conference-301174099.html

SOURCE PTC Therapeutics, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is PTC Therapeutics presenting at the Evercore ISI HealthCONx Conference?

PTC Therapeutics will present on December 1, 2020, at 11:45 a.m. ET.

Where can I watch the PTC Therapeutics conference presentation?

The presentation will be webcast live on PTC's website under the investor relations section.

How long will the PTC Therapeutics presentation be available for viewing?

The presentation will be archived and available for 30 days following the live event.

What does PTC Therapeutics focus on?

PTC Therapeutics focuses on the discovery and commercialization of medicines for patients with rare disorders.

What is the stock symbol for PTC Therapeutics?

The stock symbol for PTC Therapeutics is PTCT.

Keep reading